Related Experiment Video
Updated: Sep 13, 2025

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
Published on: August 4, 2016
CanCellCap: robust cancer cell capture across tissue types on single-cell RNA-seq data by multi-domain learning
Jiaxing Bai1, Yichun Gao1, Feng Zhou1
1Department of Automation, National Institute for Data Science in Health and Medicine, State Key Laboratory of Mariculture Breeding, Xiamen Key Laboratory of Big Data Intelligent Analysis and Decision, Xiamen University, Xiamen, Fujian, China.
CanCellCap accurately identifies cancer cells from single-cell RNA sequencing data across various tissues and platforms. This robust framework generalizes to new cancer types and species, offering valuable biological insights.
Area of Science:
- Genomics
- Computational Biology
- Cancer Research
Background:
- Single-cell RNA sequencing (scRNA-seq) reveals cancer cellular diversity but faces challenges in accurate cancer cell identification due to heterogeneity.
- Gene expression variability hinders the generalization and robustness of existing methods for cancer cell detection.
Purpose of the Study:
- To develop a universal framework, CanCellCap, for identifying cancer cells in scRNA-seq data across diverse tissues, cancers, and sequencing platforms.
- To enhance the robustness and generalization capabilities of cancer cell identification methods.
Main Methods:
- CanCellCap employs a multi-domain learning framework integrating domain adversarial learning and Mixture of Experts.
- A masking-reconstruction strategy is utilized to handle data from different sequencing platforms.
- The framework extracts common and specific gene expression patterns for cancer and normal cells across tissues.
Main Results:
- CanCellCap achieved an average accuracy of 0.977 in cancer cell identification across 13 tissue types, 23 cancer types, and 7 sequencing platforms.
- Outperformed five state-of-the-art methods on 33 benchmark datasets, demonstrating superior performance.
- Showcased high performance on unseen cancer types, tissues, and species, and accurately identified cancer spots in spatial transcriptomics data.
- Demonstrated computational efficiency, analyzing 100,000 cells in minutes, and revealed critical biomarkers and pathways.
Conclusions:
- CanCellCap offers a robust and accurate solution for cancer cell identification across diverse scRNA-seq data.
- Its strong generalization to unseen data and adaptability to spatial transcriptomics highlight its versatility for research and clinical applications.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Cancers Originate from Somatic Mutations in a Single Cell

